Cargando…

Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

Detalles Bibliográficos
Autores principales:	Carmona, F. David, Coit, Patrick, Saruhan-Direskeneli, Güher, Hernández-Rodríguez, José, Cid, María C., Solans, Roser, Castañeda, Santos, Vaglio, Augusto, Direskeneli, Haner, Merkel, Peter A., Boiardi, Luigi, Salvarani, Carlo, González-Gay, Miguel A., Martín, Javier, Sawalha, Amr H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380934/ https://www.ncbi.nlm.nih.gov/pubmed/28378796 http://dx.doi.org/10.1038/srep46012

Ejemplares similares

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
por: Carmona, F. David, et al.
Publicado: (2017)

Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study
por: Fei, Yiping, et al.
Publicado: (2009)

Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
por: Ortiz-Fernández, Lourdes, et al.
Publicado: (2023)

Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors
por: Mattioli, Irene, et al.
Publicado: (2021)

Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease
por: Parlakgul, Gunes, et al.
Publicado: (2013)

The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey
por: Kaya, Gizem A., et al.
Publicado: (2014)

Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection
por: Kaplan, Mark H., et al.
Publicado: (2019)

Promise and pitfalls of the Immunochip
por: Cortes, Adrian, et al.
Publicado: (2011)

Advances in the Treatment of Behcet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2021)

Update on the Diagnosis of Behçet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2022)

Biologic treatments in Behçet's disease
por: Alibaz-Öner, Fatma, et al.
Publicado: (2022)

Diagnostic Approaches for Large Vessel Vasculitides
por: Betrains, Albrecht, et al.
Publicado: (2021)

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
por: Celiker, Hande, et al.
Publicado: (2018)

Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspects
por: EMMUNGİL, Hakan, et al.
Publicado: (2021)

Patient Reported Outcomes in Large Vessel Vasculitides
por: Robson, Joanna, et al.
Publicado: (2021)

Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling
por: Gamrekelashvili, Jaba, et al.
Publicado: (2017)

Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides
por: Tombetti, Enrico, et al.
Publicado: (2021)

Flip-flop phenomenon in systemic sclerosis on fluorodeoxyglucose positron emission tomography/computed tomography
por: Oksuzoglu, Kevser, et al.
Publicado: (2015)

Decreasing incidence and severity of Behçet’s disease: a changing trend in epidemiological spectrum possibly associated with oral health
por: MUMCU, Gonca, et al.
Publicado: (2020)

Vasculitides
por: Weyand, Cornelia M., et al.
Publicado: (2008)

IFN-γ stimulated dental follicle mesenchymal stem cells regulate activated lymphocyte response in rheumatoid arthritis patients in vitro
por: ZIBANDEH, Noushin, et al.
Publicado: (2019)

Corrigendum to “Successful radiological detection and surgical management of type 3 choledochocele: A case report” [Radiol Case Rep 2023;18:1502–6]
por: Musleh, Asil, et al.
Publicado: (2023)

Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides
por: Schäfer, Valentin Sebastian, et al.
Publicado: (2020)

Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels
por: Harada, Hiroshi, et al.
Publicado: (2013)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci
por: Ortiz-Fernández, Lourdes, et al.
Publicado: (2016)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

Increased stiffness of median nerve in systemic sclerosis
por: Yagci, Ilker, et al.
Publicado: (2017)

cFLIP overexpression in T cells in thymoma-associated myasthenia gravis
por: Belharazem, Djeda, et al.
Publicado: (2015)

ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
por: Faraco, Juliette, et al.
Publicado: (2013)

Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
Publicado: (2018)

Impact of concomitant obstructive sleep apnea on pulmonary involvement and main pulmonary artery diameter in adults with scleroderma
por: Yakut, Tugce, et al.
Publicado: (2020)

Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus
por: Yentür, Sibel P., et al.
Publicado: (2021)

CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice
por: Villano, Gianmarco, et al.
Publicado: (2014)

Corrigendum: Turnover time of fluorescent dissolved organic matter in the dark global ocean
por: Catalá, Teresa S., et al.
Publicado: (2016)

Vasculitides in HIV Infection
por: Vega, Luis E., et al.
Publicado: (2020)

Behçet's disease: from innate to adaptive immunity
por: Direskeneli, H
Publicado: (2003)

Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease
por: Direskeneli, H.
Publicado: (2013)

CD4(+) T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS
por: Çebi, Merve, et al.
Publicado: (2020)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fg0utifhdv49j58337u55um8v6